Trade Summary

3 days ago, Menu Philippe, serving as Chief Medical Officer at SOPHiA GENETICS SA (SOPH), sold 5,000 shares at $5.50 per share, for a total transaction value of $27,524.50. Following this transaction, Menu Philippe now holds 240,780 shares of SOPH.

This sale represents a 2.03% decrease in Menu Philippe's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 4:03 PM ET, 1 day after the trade was made.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.